BioInvent is a clinical-stage biotech company (Nasdaq Stockholm: BINV) that translates cancer antibody biology into innovative immuno-oncology therapies.

ID: 1389127111336681475

linkhttp://www.bioinvent.com calendar_today03-05-2021 07:58:28